Total Payments
$3,344
2024 Payments
$258.30
Companies
36
Transactions
208
Medicare Patients
1,936
Medicare Billing
$116,227
Payment Breakdown by Category
Food & Beverage$3,059 (91.5%)
Education$146.65 (4.4%)
Gifts$137.67 (4.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,059 | 179 | 91.5% |
| Education | $146.65 | 8 | 4.4% |
| Gift | $137.67 | 21 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $634.35 | 41 | $0 (2023) |
| Daiichi Sankyo Inc. | $314.86 | 16 | $0 (2024) |
| ABBVIE INC. | $255.55 | 14 | $0 (2024) |
| ASCEND Therapeutics US, LLC | $214.66 | 33 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $181.57 | 10 | $0 (2023) |
| Astellas Pharma US Inc | $155.57 | 8 | $0 (2024) |
| Vertical Pharmaceuticals, LLC | $134.97 | 8 | $0 (2019) |
| Myriad Women's Health, Inc. | $113.15 | 1 | $0 (2023) |
| Duchesnay USA Incorporated | $111.31 | 5 | $0 (2019) |
| Myovant Sciences Inc. | $109.27 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $258.30 | 11 | Astellas Pharma US Inc ($86.83) |
| 2023 | $370.82 | 14 | Myriad Women's Health, Inc. ($113.15) |
| 2022 | $474.92 | 24 | Myovant Sciences Inc. ($67.37) |
| 2021 | $240.33 | 13 | AbbVie Inc. ($68.09) |
| 2020 | $117.28 | 7 | Daiichi Sankyo Inc. ($53.53) |
| 2019 | $660.56 | 61 | ASCEND Therapeutics US, LLC ($170.73) |
| 2018 | $606.13 | 36 | PFIZER INC. ($155.27) |
| 2017 | $615.45 | 42 | PFIZER INC. ($323.58) |
All Payment Transactions
208 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $30.19 | General |
| 11/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Biological | ||||||
| 10/24/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $32.76 | General |
| 09/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Biological | ||||||
| 08/14/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/22/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: WOMENS HEALTH | ||||||
| 07/15/2024 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 06/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: UROLOGY | ||||||
| 05/22/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Biological | ||||||
| 01/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Biological | ||||||
| 11/30/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $113.15 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Central Nervous System | ||||||
| 09/11/2023 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 08/29/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: WOMENS HEALTH | ||||||
| 08/24/2023 | Hologic Sales and Service, LLC | THINPREP 2000 PROCESSOR (Device), APTIMA | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Diagnostics | ||||||
| 07/13/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Biological | ||||||
| 06/22/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: WOMENS HEALTH | ||||||
| 05/24/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Urology | ||||||
| 05/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Womens Health | ||||||
| 03/28/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/24/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Urology | ||||||
| 03/09/2023 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Womens Health | ||||||
| 02/07/2023 | Mycovia Pharmaceuticals, Inc. | Vivjoa (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Infections and Infectious Diseases | ||||||
| 01/25/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $23.23 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 394 | 420 | $43,051 | $22,209 |
| 2022 | 8 | 491 | 519 | $78,299 | $29,627 |
| 2021 | 9 | 529 | 583 | $84,630 | $33,439 |
| 2020 | 9 | 522 | 590 | $79,887 | $30,951 |
Total Patients
1,936
Total Services
2,112
Medicare Billing
$116,227
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 163 | 163 | $9,780 | $6,419 | 65.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 81 | $10,692 | $5,087 | 47.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 90 | 90 | $6,480 | $3,794 | 58.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $8,077 | $3,242 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 33 | $6,402 | $3,074 | 48.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,620 | $593.68 | 36.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 172 | 172 | $10,320 | $6,893 | 66.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 109 | $14,388 | $6,662 | 46.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 98 | 98 | $7,056 | $4,194 | 59.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 47 | 47 | $9,259 | $3,952 | 42.7% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Facility | 2022 | 19 | 19 | $27,550 | $3,653 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 24 | $4,656 | $2,227 | 47.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 20 | 20 | $2,700 | $1,052 | 39.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 26 | 30 | $2,370 | $994.21 | 41.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 94 | 137 | $18,084 | $8,711 | 48.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 182 | 182 | $10,920 | $7,235 | 66.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 115 | 115 | $8,280 | $4,968 | 60.0% |
| 58558 | Biopsy and/or removal of polyp of the uterus using an endoscope | Facility | 2021 | 21 | 21 | $27,720 | $4,022 | 14.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 38 | 38 | $7,486 | $3,132 | 41.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 23 | $4,462 | $2,252 | 50.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 25 | 36 | $2,844 | $1,532 | 53.9% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 20 | 20 | $2,700 | $1,003 | 37.1% |
| 57160 | Fitting and insertion of vaginal support device | Office | 2021 | 11 | 11 | $2,134 | $585.05 | 27.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 103 | 158 | $20,856 | $8,027 | 38.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 177 | 177 | $10,620 | $7,274 | 68.5% |
About Dr. John Ellington, MD
Dr. John Ellington, MD is a Gynecology healthcare provider based in Lakeland, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750353918.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Ellington, MD has received a total of $3,344 in payments from pharmaceutical and medical device companies, with $258.30 received in 2024. These payments were reported across 208 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,059).
As a Medicare-enrolled provider, Ellington has provided services to 1,936 Medicare beneficiaries, totaling 2,112 services with total Medicare billing of $116,227. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Lakeland, FL
- Active Since 02/02/2006
- Last Updated 11/27/2023
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1750353918
Products in Payments
- INJECTAFER (Drug) $289.95
- PREMARIN (Drug) $258.81
- ESTROGEL (Drug) $183.15
- PVC (Drug) $138.92
- DIVIGEL (Drug) $134.97
- PREMARIN ORALS (Drug) $134.17
- Osphena (Drug) $122.92
- INTRAROSA (Drug) $122.75
- MYRISK (Device) $113.15
- MYFEMBREE (Drug) $109.27
- Veozah (Drug) $101.53
- RS Harmony Test Related Products (Device) $101.31
- Kyleena (Drug) $95.26
- Mirena (Drug) $86.31
- ESTRING (Drug) $84.84
- Xulane (Drug) $77.04
- Orilissa (Drug) $65.86
- Balcoltra (Drug) $61.61
- LO LOESTRIN FE (Drug) $56.95
- Myrbetriq (Drug) $54.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.